Cargando…
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587328/ https://www.ncbi.nlm.nih.gov/pubmed/37466796 http://dx.doi.org/10.1007/s00432-023-05137-8 |
| _version_ | 1785123339095769088 |
|---|---|
| author | Fleischer, Anna Zapf, Larissa Allgaier, Johannes Jordan, Karin Gelbrich, Götz Pryss, Rüdiger Schobel, Johannes Bittrich, Max Einsele, Hermann Kortüm, Martin Maatouk, Imad Weinhold, Niels Rasche, Leo |
| author_facet | Fleischer, Anna Zapf, Larissa Allgaier, Johannes Jordan, Karin Gelbrich, Götz Pryss, Rüdiger Schobel, Johannes Bittrich, Max Einsele, Hermann Kortüm, Martin Maatouk, Imad Weinhold, Niels Rasche, Leo |
| author_sort | Fleischer, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10587328 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105873282023-10-21 A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials Fleischer, Anna Zapf, Larissa Allgaier, Johannes Jordan, Karin Gelbrich, Götz Pryss, Rüdiger Schobel, Johannes Bittrich, Max Einsele, Hermann Kortüm, Martin Maatouk, Imad Weinhold, Niels Rasche, Leo J Cancer Res Clin Oncol Research Springer Berlin Heidelberg 2023-07-19 2023 /pmc/articles/PMC10587328/ /pubmed/37466796 http://dx.doi.org/10.1007/s00432-023-05137-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Fleischer, Anna Zapf, Larissa Allgaier, Johannes Jordan, Karin Gelbrich, Götz Pryss, Rüdiger Schobel, Johannes Bittrich, Max Einsele, Hermann Kortüm, Martin Maatouk, Imad Weinhold, Niels Rasche, Leo A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title | A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title_full | A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title_fullStr | A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title_full_unstemmed | A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title_short | A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| title_sort | patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials |
| topic | Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587328/ https://www.ncbi.nlm.nih.gov/pubmed/37466796 http://dx.doi.org/10.1007/s00432-023-05137-8 |
| work_keys_str_mv | AT fleischeranna apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT zapflarissa apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT allgaierjohannes apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT jordankarin apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT gelbrichgotz apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT pryssrudiger apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT schobeljohannes apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT bittrichmax apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT einselehermann apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT kortummartin apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT maatoukimad apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT weinholdniels apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT rascheleo apatientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT fleischeranna patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT zapflarissa patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT allgaierjohannes patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT jordankarin patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT gelbrichgotz patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT pryssrudiger patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT schobeljohannes patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT bittrichmax patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT einselehermann patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT kortummartin patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT maatoukimad patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT weinholdniels patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials AT rascheleo patientsurveyindicatesqualityoflifeandprogressionfreesurvivalasequallyimportantoutcomemeasuresinmultiplemyelomaclinicaltrials |